about
Circulating CD36 is reduced in HNF1A-MODY carriersCirculating sCD36 is associated with unhealthy fat distribution and elevated circulating triglycerides in morbidly obese individuals.Prospects and limitations of antibody-mediated clearing of lipoproteins from blood plasma prior to nanoparticle tracking analysis of extracellular vesiclesLong-term delivery of nerve growth factor by encapsulated cell biodelivery in the Göttingen minipig basal forebrain.Insulin resistance in skeletal muscles in patients with NIDDM.In vitro Incubation of Platelets with oxLDL Does Not Induce Microvesicle Release When Measured by Sensitive Flow CytometryThe Impact of Lipoprotein-Associated Oxidative Stress on Cell-Specific Microvesicle Release in Patients with Familial Hypercholesterolemia.A flow cytometric method for characterization of circulating cell-derived microparticles in plasma.Biochemical markers of bone turnover in diabetes patients--a meta-analysis, and a methodological study on the effects of glucose on bone markers.Reduced sCD36 following weight loss corresponds to improved insulin sensitivity, dyslipidemia and liver fat in obese children.Arterial Stiffness, Thickness and Association to Suitable Novel Markers of Risk at the Origin of Cardiovascular Disease in Obese ChildrenThe basal kinetic parameters of glycogen synthase in human myotube cultures are not affected by chronic high insulin exposure.Effect of weight reduction on insulin sensitivity, sex hormone-binding globulin, sex hormones and gonadotrophins in obese children.The macrophage activation marker sCD163 is associated with changes in NAFLD and metabolic profile during lifestyle intervention in obese children.Insulin action and long-term electrically induced training in individuals with spinal cord injuries.Expression of insulin regulatable glucose transporters in skeletal muscle from type 2 (non-insulin-dependent) diabetic patients.Soluble CD36 and risk markers of insulin resistance and atherosclerosis are elevated in polycystic ovary syndrome and significantly reduced during pioglitazone treatment.Bone Structure and Predictors of Fracture in Type 1 and Type 2 Diabetes.Differences in biochemical bone markers by diabetes type and the impact of glucose.Elevated platelet expression of CD36 may contribute to increased risk of thrombo-embolism in active inflammatory bowel disease.Intracellular skeletal muscle glucose metabolism is differentially altered by dexamethasone treatment of normoglycemic relatives of type 2 diabetic patients.Diurnal variation of the serum leptin concentration in patients with anorexia nervosa.Circulating sCD36 levels in patients with non-alcoholic fatty liver disease and controls.Physical training increases muscle GLUT4 protein and mRNA in patients with NIDDM.Metformin ameliorates diabetes but does not normalize the decreased GLUT 4 content in skeletal muscle of obese (fa/fa) Zucker rats.Peripheral glucose uptake and skeletal muscle GLUT4 content in man: effect of insulin and free fatty acids.Eccentric contractions decrease glucose transporter transcription rate, mRNA, and protein in skeletal muscle.Intact regulation of muscle expression and circulating levels of myokines in response to exercise in patients with type 2 diabetes.Bariatric surgery reduces CD36-bearing microvesicles of endothelial and monocyte originBLTR1 and CD36 Expressing Microvesicles in Atherosclerotic Patients and Healthy IndividualsMinimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelinesSoluble CD36 in Plasma Is Increased in Patients With Symptomatic Atherosclerotic Carotid Plaques and Is Related to Plaque InstabilityCirculating exosomes deliver free fatty acids from the bloodstream to cardiac cells: Possible role of CD36.Variation in absorption of NPH insulin due to intramuscular injectionProtein kinase activity of the partially purified insulin receptor from human adipocytesGlucose processing during the intravenous glucose tolerance testDecreased skeletal muscle phosphotyrosine phosphatase (PTPase) activity towards insulin receptors in insulin-resistant Zucker rats measured by delayed Europium fluorescenceC-peptide stimulates glucose transport in isolated human skeletal muscle independent of insulin receptor and tyrosine kinase activationReciprocal GLUT-1 and GLUT-4 expression and glucose transport in denervated musclesQuantity of Na/K-ATPase and glucose transporters in the plasma membrane of rat adipocytes is reduced by in vivo triiodothyronine
P50
Q28533348-04CA5E8D-70D0-48AD-B24A-C254A3EE4A18Q33554854-C093042E-D7F9-4FF3-9DF8-A54A568AC504Q33604672-41162117-73A3-4842-9F7B-8DF20162D18FQ34382945-067D4ABC-B692-4A26-8DEF-C1AB0129A674Q35981579-B9D7D7D1-2A2B-4AF7-BBBE-E8AB9B1B5FEFQ36351154-632835D5-0F78-4862-86E7-187FCF4FF29DQ36564652-B7E86934-673D-4805-912C-DBEE7E2B0B24Q37563984-A4C66923-F4ED-4ED3-9998-4F8F4C5474BAQ38200005-85B227A2-F3A6-417E-93AE-688C2F88F467Q39702732-FA28023D-0852-4D66-A690-ECBD94D102F9Q41454811-CCCBEE23-D54E-42D3-96FE-604094B7CEFFQ42513614-D5D3E8A6-FBE8-44F3-81B0-5042B98F1648Q42911723-0265EC90-D37F-4E4D-AE09-3630F73F8F72Q43544546-0CD48F7A-D781-4DDE-BB40-E465250B848DQ43688804-F759B7C5-B8BC-496A-812A-BAAED4127DBCQ46578328-CDBD83ED-F504-4D76-8B80-909C227D8E0FQ46901919-1084AA9B-03A8-4F61-8752-E5C76A2D2B54Q47917349-F44DC9EB-617D-456A-BAB6-71033B1D138DQ47967573-2FF20EE6-C2F2-4FB4-B7CB-03E78835AC78Q47991595-E6EC054F-232D-4B06-AEB2-C398BBDC2DECQ51561058-E0F6B6B0-15CD-46C9-A3FA-F55B7923E2F2Q51568424-70A905BA-BEB5-4230-927B-5F2D822C1282Q53758887-30A870EE-44DB-49C3-BE9B-877C88BA247DQ54200208-6B9E0300-9538-4CD7-9671-904E796FE0AFQ54239227-A3FC2FB6-BF76-47C7-9D07-F058AB0713A2Q54264827-48EBDDC2-B9CC-4348-95F4-A8860A1DA5CCQ55067053-15ED45BF-031B-4768-9FD4-9A2FE2BC7FD1Q55391745-1E24E8EE-6259-493D-8421-1ABA5C7F04D8Q58576944-000C2E2A-8669-48F2-AA96-EEDA2EBD2F07Q58693913-4B8CAC1C-CD18-471D-8F0A-A0D12B2483A2Q60326168-50627B86-4ECE-4231-96C7-47F1EA3F86D5Q61066384-C166B514-32B5-4373-9884-808ABFBE0A21Q64965860-9FCD69AA-1834-42C5-93D4-717A61A9FA83Q68927088-793BFDCE-D886-4904-B882-B9965D6B3181Q70039642-A42924BD-112B-4C39-8204-DA95FD21D95BQ71061277-16EECE55-BF59-47C4-9FCF-5FBB4AA9BE9CQ71090491-64E553E4-A163-4AB1-A4A2-4CA2EEC1DFDCQ71297583-6EC7C9E4-1139-47F4-BAEE-4BAA6F7E6F74Q71404492-D195DCF3-A1EB-447E-84FC-9B3AF2C5D226Q71795600-71CEE74B-228C-4DF4-934C-933C711B98F6
P50
description
Forscher
@de
chercheur
@fr
investigador
@es
researcher
@en
ricercatore
@it
研究者
@zh
name
Aase Handberg
@ast
Aase Handberg
@en
Aase Handberg
@es
Aase Handberg
@nl
type
label
Aase Handberg
@ast
Aase Handberg
@en
Aase Handberg
@es
Aase Handberg
@nl
prefLabel
Aase Handberg
@ast
Aase Handberg
@en
Aase Handberg
@es
Aase Handberg
@nl
P1153
7003559498
P214
4775149108706668780006
P31
P496
0000-0001-5719-203X
P7859
viaf-4775149108706668780006